These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27613823)

  • 1. Development of nonfibrotic left ventricular hypertrophy in an ANG II-induced chronic ovine hypertension model.
    Klatt N; Scherschel K; Schad C; Lau D; Reitmeier A; Kuklik P; Muellerleile K; Yamamura J; Zeller T; Steven D; Baldus S; Schäffer B; Jungen C; Eickholt C; Wassilew K; Schwedhelm E; Willems S; Meyer C
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27613823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
    Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression and regression of left ventricular hypertrophy and myocardial fibrosis in a mouse model of hypertension and concomitant cardiomyopathy.
    Kwiecinski J; Lennen RJ; Gray GA; Borthwick G; Boswell L; Baker AH; Newby DE; Dweck MR; Jansen MA
    J Cardiovasc Magn Reson; 2020 Aug; 22(1):57. PubMed ID: 32758255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.
    Wang LJ; He JG; Ma H; Cai YM; Liao XX; Zeng WT; Liu J; Wang LC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):481-7. PubMed ID: 15897115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
    Salah E; Bastacky SI; Jackson EK; Tofovic SP
    J Cardiovasc Pharmacol; 2019 Mar; 73(3):165-177. PubMed ID: 30839510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baroreflex control of heart rate and cardiac hypertrophy in angiotensin II-induced hypertension in rabbits.
    Malpas SC; Groom AS; Head GA
    Hypertension; 1997 Jun; 29(6):1284-90. PubMed ID: 9180630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.
    Ichihara S; Senbonmatsu T; Price E; Ichiki T; Gaffney FA; Inagami T
    Circulation; 2001 Jul; 104(3):346-51. PubMed ID: 11457756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains.
    Cardin S; Scott-Boyer MP; Praktiknjo S; Jeidane S; Picard S; Reudelhuber TL; Deschepper CF
    Hypertension; 2014 Nov; 64(5):1040-6. PubMed ID: 25069667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Katoh K; Fukuchi S
    Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload.
    Ruzicska E; Foldes G; Lako-Futo Z; Sarman B; Wellmann J; Szenasi G; Tulassay Z; Ruskoaho H; Toth M; Somogyi A
    J Hypertens; 2004 Jun; 22(6):1191-200. PubMed ID: 15167455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of multiparametric CMR in left ventricular hypertrophy.
    Nordin S; Dancy L; Moon JC; Sado DM
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):577-585. PubMed ID: 29500729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension.
    Schmieder RE; Langenfeld MR; Friedrich A; Schobel HP; Gatzka CD; Weihprecht H
    Circulation; 1996 Sep; 94(6):1304-9. PubMed ID: 8822984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
    Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
    Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin modulates hemodynamic and cardiac effects of angiotensin II in conscious rats.
    Luodonpää M; Leskinen H; Ilves M; Vuolteenaho O; Ruskoaho H
    Am J Physiol Regul Integr Comp Physiol; 2004 Jun; 286(6):R1085-92. PubMed ID: 14751847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation.
    Zouein FA; Zgheib C; Hamza S; Fuseler JW; Hall JE; Soljancic A; Lopez-Ruiz A; Kurdi M; Booz GW
    Hypertens Res; 2013 Jun; 36(6):496-503. PubMed ID: 23364341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure.
    Lund AK; Goens MB; Kanagy NL; Walker MK
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):177-87. PubMed ID: 14644620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.